Skip to main content
. 2016 Feb;83:9–16. doi: 10.1016/j.bone.2015.10.004

Fig. 2.

Fig. 2

Osteolytica reduces inter-user variability compared to a 2-D ImageJ analysis method. (A) Representative micro-CT full-face images of tibia (n = 5), from mice injected with 1 × 106 U266 cells at the end stage of disease, used to assess inter-user variance. (B) Bone lesion area showing inter-user variance when using the 2-D ImageJ method (19.6%) (i.) and when using Osteolytica (0.53%) (ii.).